CITADEL ADVISORS LLC EKG FIRST TR EXCHANGE-TRADED FD

Ownership history in CITADEL ADVISORS LLC  ·  9 quarters on record

AI Ownership Summary

CITADEL ADVISORS LLC reported FIRST TR EXCHANGE-TRADED FD (EKG) in 9 quarterly 13F filings from 2024 Q1 through 2026 Q1. The latest visible filing shows EKG at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this EKG ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was CITADEL ADVISORS LLC's position in FIRST TR EXCHANGE-TRADED FD, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

EKG was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2025 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q1 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How CITADEL ADVISORS LLC held EKG — position size vs. price
% of Fund (quarterly)    EKG price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 9 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 ADDED 27,377 +2,325 +9.3% 0.00% $444K 2026-05-15 $15.72
2025 Q4 ADDED 25,052 +12,404 +98.1% 0.00% $476K 2026-02-17 $17.64
2025 Q3 REDUCED 67.0% +10.1% 12,648 -25,670 -67.0% 0.00% $220K 2025-11-14 $18.39
2025 Q2 ADDED 38,318 +6,527 +20.5% 0.00% $682K 2025-08-14 $17.38
2025 Q1 ADDED 31,791 +5,162 +19.4% 0.00% $497K 2025-05-15 $16.88
2024 Q4 REDUCED 26,629 -111 -0.4% 0.00% $452K 2025-02-14 $18.52
2024 Q3 ADDED 26,740 +2,281 +9.3% 0.00% $455K 2024-11-14 $17.06
2024 Q2 REDUCED 24,459 -651 -2.6% 0.00% $380K 2024-08-14 $15.98
2024 Q1 INITIATED 25,110 0.00% $426K 2024-05-15 $16.52

FAQ About CITADEL ADVISORS LLC and EKG

These are the practical questions this page is built to answer before you even open the full history table.

How long has CITADEL ADVISORS LLC reported owning EKG?

CITADEL ADVISORS LLC reported EKG across 9 quarterly 13F filings, from 2024 Q1 through 2026 Q1.

What was the largest reported EKG position in CITADEL ADVISORS LLC's portfolio?

The largest reported portfolio weight for EKG was 0.00% in 2025 Q2.

What is the latest reported EKG position on this page?

The most recent filing on this page is 2026 Q1, when CITADEL ADVISORS LLC reported 27,377 shares, equal to 0.00% of portfolio, with an estimated market value of $444K.

What does the chart on this EKG ownership page compare?

The chart compares CITADEL ADVISORS LLC's quarterly EKG portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did CITADEL ADVISORS LLC time their EKG position?

Based on 13F filing dates vs. subsequent EKG price moves, CITADEL ADVISORS LLC correctly timed 5 out of 8 reported position changes (62%). The annualised alpha on EKG relative to SPY over the holding period was -18.4%.

← Back to CITADEL ADVISORS LLC Holdings